SACRAMENTO BUSINESS JOURNAL INTERVIEW WITH CATE DYER

November 17, 2017
Back to Blog Home Page

Cate Dyer

CEO & Founder

of StemExpress

A local journalist talks with StemExpress CEO, Cate Dyer, about the importance of her company’s mission to accelerate research and what that means for the future of patient care and the development of new treatments.

Read the Article

CGT Global Attends Advanced Therapies USA 2024 to Support Cell and Gene Therapy Innovation

November 12, 2024
Read More

Protected: Optimizing Engraftment Rates for Researchers in Cord Blood and PBMNC Studies

October 31, 2024
Read More

EIN Presswire: CGT Global Receives Approval Aiding Scientists in Discovering Life-Saving Cures

June 24, 2024
Read More

EIN Presswire: CGT Global and Austin Financial Partner to Drive Momentum for Cutting-Edge Cell Therapy Treatments and Cures

June 24, 2024
Read More

EIN Presswire: CGT Global Selected as Strategic Partner to Expand Cell and Gene Therapies Across the United States

June 24, 2024
Read More
CGT Global the future of healthcare - Final mile to the patient

KFBK & NPR Interviews with CGT Global

January 25, 2024
Read More